Skip to search boxSkip to navigationSkip to main content

Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia

  • Alfonso Quintás-Cardama(corresponding author)
    ,
  • Hagop M. Kantarjian
    ,
*Corresponding author for this work
  • University of Texas MD Anderson Cancer Center
    ,
  • University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Open access

Abstract

<p>Background: Although the vast majority of patients with chronic myeloid leukemia (CML) respond to the tyrosine kinase inhibitor (TKI) imatinib mesylate, resistance might occur de novo or during treatment. Methods: The authors reviewed the known mechanisms of primary and secondary resistance to imatinib and other TKIs used in the management of CML. Results: Mutations within the kinase domain of BCR-ABLI account for 30% to 40% of cases of imatinib resistance. Other mechanisms include BCR-ABLI amplification, overexpression of the SRC family of kinases, and pharmacokinetic and pharmacodynamic factors. Conclusions: Although not all resistance mechanisms have been identified and understood, several agents based on the known mechanisms have already been designed and developed and are beginning clinical trials.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 122-131 (10 pages)

Journal (Volume, Issue Number)

Cancer Control (Volume 16, Issue 2)

Publication milestones

  • Published - 04/2009

Publication status

Published - 04/2009

ISSN

1073-2748

Publication IDs

  • Scopus: 65249185560
  • PubMed: 19337198

Publication metrics

Metrics

Scopus
citations
SciVal
citations
167
SciVal
FWCI
4.55
SciVal
Author count
3
SciVal
Paper percentile
98
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
168
Mentions
1
Citation count
219